Abstract
We have completed a phase I study to test feasibility and toxicity of immunotherapy of hepatic metastases from colorectal carcinoma by direct gene transfer of HLA-B7, a MHC class I gene. Eligible patients were HLA-B7 negative, immunocompetent by PHA lymphocyte stimulation and had at least two measurable hepatic lesions on CT scan for measurement of response of the injected lesion, as well as evaluation of possible distant response. Under ultrasonographic guidance the hepatic lesions were injected with Allovectin-7, a liposomal vector containing the combination of the HLA-B7 gene with β2-microglobulin formulated with the lipid DMRIE-DOPE. Eligible patients were injected on two schedules. On the first schedule patients received an injection on day 1 and the injected lesion was biopsied to determine transfection every 2 weeks for 8 weeks. Doses were escalated from 10 μg to 50 μg to 250 μg with three patients treated at each level. The second schedule included multiple injections of 10 μg. Three patients received injections on days 1 and 15. Three patients received injections on days 1, 15 and 29. A total of 15 patients have completed treatment. The plasmid DNA was detected in 14 of 15 patients (93%) by PCR. In five of 15 patients (33%) mRNA was also detected. The HLA-B7 protein was detected in five of eight patients (63%) by immunohistochemistry and in seven of 14 patients (50%) tested by fluorescence activated cell sorting (FACS) analysis. There has been no serious toxicity directly attributable to allovectin-7. Our results suggest that liposomal gene transfer by direct injection is feasible and non-toxic. Further studies will be necessary in order to establish the therapeutic efficacy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubin, J., Galanis, E., Pitot, H. et al. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Ther 4, 419–425 (1997). https://doi.org/10.1038/sj.gt.3300396
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300396
Keywords
This article is cited by
-
Mechanisms of action underlying the immunotherapeutic activity of Allovectin in advanced melanoma
Cancer Gene Therapy (2012)
-
Immunotherapy for liver tumors: present status and future prospects
Journal of Biomedical Science (2009)
-
Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery
Gene Therapy (2003)
-
Clinical development of gene therapy for colorectal cancer
Nature Reviews Cancer (2003)
-
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
Gene Therapy (2002)